The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization
Clinical trial NCT05011916 · UNKNOWN
Trial details
- NCT number
- NCT05011916
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-10
- Primary completion
- 2022-08-09
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.